Balentine LLC’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-5,369
| Closed | -$745K | – | 293 |
|
|
2024
Q1 | $745K | Buy |
5,369
+551
| +11% | +$76.4K | 0.02% | 229 |
|
|
2023
Q4 | $598K | Buy |
+4,818
| New | +$598K | 0.02% | 248 |
|
|
2023
Q3 | – | Sell |
-1,937
| Closed | -$249K | – | 571 |
|
|
2023
Q2 | $249K | Buy |
+1,937
| New | +$249K | 0.01% | 431 |
|
|
2020
Q3 | – | Sell |
-664
| Closed | -$67K | – | 346 |
|
|
2020
Q2 | $67K | Buy |
664
+32
| +5% | +$3.23K | ﹤0.01% | 199 |
|
|
2020
Q1 | $43K | Buy |
632
+156
| +33% | +$10.6K | ﹤0.01% | 193 |
|
|
2019
Q4 | $26K | Buy |
+476
| New | +$26K | ﹤0.01% | 275 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 634 |
|
|
2017
Q3 | – | Sell |
-460
| Closed | -$8K | – | 650 |
|
|
2017
Q2 | $8K | Buy |
460
+104
| +29% | +$1.81K | ﹤0.01% | 461 |
|
|
2017
Q1 | $8K | Sell |
356
-28
| -7% | -$629 | ﹤0.01% | 434 |
|
|
2016
Q4 | $6K | Buy |
384
+60
| +19% | +$938 | ﹤0.01% | 441 |
|
|
2016
Q3 | $7K | Sell |
324
-4
| -1% | -$86 | ﹤0.01% | 389 |
|
|
2016
Q2 | $7K | Buy |
+328
| New | +$7K | ﹤0.01% | 381 |
|